PHI with Echinococcus multilocularis infection of other organs
How does this condition affect your private health insurance?
Alveolar Echinococcosis (AE), caused by *Echinococcus multilocularis*, is a rare but severe parasitic zoonosis primarily affecting the liver, though it can metastasize to lungs, brain, or bones. Humans acquire infection by ingesting eggs, often from fox or dog feces. The larval cysts grow invasively, resembling a malignant tumor, causing chronic inflammation and progressive organ damage. Symptoms, including abdominal pain, jaundice, and weight loss, develop slowly over many years. Untreated, AE is usually fatal due to extensive organ damage or metastases. Early diagnosis and lifelong anthelminthic treatment with benzimidazoles are crucial for managing this devastating disease and preventing fatal outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Months to years (for symptomatic presentation; initial parasitic development is asymptomatic for years)
Duration of Illness (Lifetime)
Chronic, often lifelong requiring continuous medical management
Cost of Treatment (Initial)
High, involving extensive diagnostics, potential surgery, and initiation of long-term medication, estimated tens to hundreds of thousands USD.
Cost of Treatment (Lifetime)
Very high, due to lifelong medication, regular follow-ups, and management of complications, potentially hundreds of thousands to millions USD.
Mortality Rate
High (if untreated, nearly 100% fatal; with adequate treatment, mortality significantly reduced but still 5-20% over 10 years).
Risk of Secondary Damages
Very high; severe organ damage (e.g., liver failure, lung lesions, brain cysts), biliary obstruction, portal hypertension, secondary bacterial infections, cachexia, and neurological deficits.
Probability of Full Recovery
Low; complete parasitic eradication without lifelong medication is rare. Surgical cure is only possible in very early, localized cases amenable to complete resection.
Underlying Disease Risk
None directly, but immunosuppression (e.g., HIV, organ transplant) can lead to more aggressive and rapidly progressing disease.